Swiss National Bank’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-117,542
| Closed | -$2.22M | – | 2590 |
|
|
2019
Q3 | $2.22M | Buy |
117,542
+4,400
| +4% | +$83K | ﹤0.01% | 1599 |
|
|
2019
Q2 | $1.33M | Hold |
113,142
| – | – | ﹤0.01% | 1957 |
|
|
2019
Q1 | $1.54M | Buy |
113,142
+3,500
| +3% | +$47.8K | ﹤0.01% | 1823 |
|
|
2018
Q4 | $1.12M | Hold |
109,642
| – | – | ﹤0.01% | 1936 |
|
|
2018
Q3 | $1.83M | Hold |
109,642
| – | – | ﹤0.01% | 1772 |
|
|
2018
Q2 | $1.73M | Hold |
109,642
| – | – | ﹤0.01% | 1792 |
|
|
2018
Q1 | $1.39M | Hold |
109,642
| – | – | ﹤0.01% | 1884 |
|
|
2017
Q4 | $1.26M | Buy |
109,642
+12,300
| +13% | +$141K | ﹤0.01% | 1951 |
|
|
2017
Q3 | $1.19M | Buy |
97,342
+31,000
| +47% | +$380K | ﹤0.01% | 1951 |
|
|
2017
Q2 | $760K | Hold |
66,342
| – | – | ﹤0.01% | 2217 |
|
|
2017
Q1 | $1.38M | Buy |
66,342
+1,700
| +3% | +$35.4K | ﹤0.01% | 1812 |
|
|
2016
Q4 | $1.35M | Hold |
64,642
| – | – | ﹤0.01% | 1836 |
|
|
2016
Q3 | $2.12M | Buy |
64,642
+1,100
| +2% | +$36K | ﹤0.01% | 1468 |
|
|
2016
Q2 | $1.59M | Buy |
63,542
+26,742
| +73% | +$668K | ﹤0.01% | 1668 |
|
|
2016
Q1 | $868K | Buy |
36,800
+8,600
| +30% | +$203K | ﹤0.01% | 1993 |
|
|
2015
Q4 | $931K | Hold |
28,200
| – | – | ﹤0.01% | 1872 |
|
|
2015
Q3 | $924K | Buy |
28,200
+3,900
| +16% | +$128K | ﹤0.01% | 1823 |
|
|
2015
Q2 | $1.29M | Buy |
+24,300
| New | +$1.29M | ﹤0.01% | 1624 |
|